glycosylation site in its stalk region, and isoform B has no glycosylation site because it lacks a stalk region.
11) N-Linked glycosylation on cell surface receptors is generally recognized to increase the stability of a molecule, promote cell surface expression, and often modulate ligand-binding activities. 17, 18) The importance of glycosylation on some C-type lectin family receptors has also been reported, [19] [20] [21] but the effect of the glycosylation of Dectin-1 has not been clarified. In this study, we generated various glycosylation-site mutants of murine and human Dectin-1, and demonstrated that Nlinked glycosylation on Dectin-1 is essential for cell surface expression, ligand-binding, and the activation of nuclear factor kB (NF-kB) together with toll-like receptor 2 (TLR2). These results suggest that N-linked glycosylation affects the anti-fungal activities of Dectin-1.
MATERIALS AND METHODS
Polysaccharides SPG (schizophyllan) is a 1,6-branched 1,3-b-glucan from Schizophyllum commune 22) and was purchased from Kaken Pharmaceutical Co. (Tokyo, Japan). Zymosan (Zymosan A; Sigma) is a cell wall preparation of Saccharomyces cerevisiae which contains b-glucan polymers, amannan, protein, and lipid. 23) As we previously reported that Zymosan may contain an endotoxin-like substance in the water soluble phase, 24) we used the water insoluble fraction in this study. Zymosan particles were washed twice with sterilized water and autoclaved at 121°C for 20 min prior to use.
Preparation of SPG-Biotin The 1,6-monoglucosylbranched 1,3-b-D-glucan SPG is originally manufactured from mycelium culture fluid of S. commune, and is used clinically as a biological response modifier in Japan. SPG-biotin was prepared as previously described. 15) Briefly, SPG was partially periodate oxidized from its side-branched glucose residues, and the resulting aldehyde groups were conjugated with biotin hydrazide (Vector Laboratories) by reductive amination using sodium cyanoborohydride (Sigma). The biotinylated SPG (SPG-biotin) was dialyzed against phosphate-buffered saline (PBS) containing 0.05% NaN 3 and stored at 4°C until used.
Cell Culture HEK293 cells (CRL-1573; Cell Resource Center for Biomedical Research, Tohoku University, Sendai, Japan) were maintained in Dulbecco's Modified Eagle's Medium Nutrient Mixture F-12 HAM (DMEM/HAM; Sigma) with 50 mg/ml of Gentamicin Sulfate (Sigma) and 10% heat-inactivated fetal bovine serum, FBS (Gibco).
Preparation of Dectin-1 Transfectants Dectin-1 cDNAs were amplified by reverse transcription-PCR from total RNA prepared from human peripheral blood cells from healthy donors or a murine macrophage cell line, RAW264.7 (RIKEN Cell Bank, Tsukuba Japan). Murine and human Dectin-1 cDNAs were inserted into p3XFLAG CMV-14 Expression Vector (Sigma). Plasmids for glycosylation site mutants of Dectin-1 were constructed by PCR-mediated mutagenesis using KOD-Plus DNA polymerase (TOYOBO, Osaka, Japan). Briefly, forward and reverse oligonucleotide primers composed of 30 bases (Sigma Genosys, Tokyo, Japan) were designed with the 14th and/or 15th nucleotide residue replacing code Ala, Asn or Ser to disrupt or generate the glycosylation amino acid sequence, Asn-X-Ser/Thr. The genes encoding wild-type Dectin-1 mutant cDNAs in p3XFLAG CMV-14 vector were transduced into HEK293 cells using FuGENE6 Transfection Reagent (Roche).
Deglycosylation of Dectin-1 Deglycosylation of Dectin-1 was carried out with whole HEK293 cells expressing FLAG-tagged wild-type Dectin-1 and PNGase F (New England Biolabs) according to the manufacturer's recommendations. Briefly, the cells were solubilized in glycoprotein denaturing buffer and incubated at 100°C for 10 min. Then, 10ϫG7 Reaction Buffer, 10% NP-40 and PNGase F were added and the samples were incubated at 37°C for 3 h. The deglycosylated proteins were subjected to SDS-PAGE and immunoblotting using anti-FLAG antibody.
Detection of Whole Cell Expression of Dectin-1 Mutants by Western Blotting HEK293 cells (1ϫ10 5 cells) were transfected with Dectin-1 or other glycosylation mutants and lysed in SDS sample buffer containing 4% SDS, 15% 2-mercaptoethanol, 10% sucrose, and 0.125 M Tris-HCl. The samples were incubated at 100°C for 5 min. and subjected to SDS-PAGE on 12% polyacrylamide gels. After electrophoresis, proteins were electrotransferred onto nitrocellulose membranes and probed with 0.4 mg/ml of ANTI-FLAG Bio M2 (Sigma). The bound anti-FLAG antibodies were detected with horseradish peroxidase-conjugated streptavidin (Pharmingen). Peroxidase activities were visualized using ECL plus (Amersham Bioscience, U.K.) following the procedure suggested by the manufacturer.
Analysis of Cell Surface Expression of Transfectants Transfectants of Dectin-1 wild type or the glycosylation mutants (5ϫ10 5 cells) were suspended in 100 ml of 50 mM Tris-buffered saline (pH 7.2) containing 0.5% bovine serum albumin (Sigma) and incubated 30 min on ice with 50 mg/ml of SPG-biotin or 10 mg/ml of ANTI-FLAG BioM2 (Sigma). The cells were washed twice with Tris-buffered saline and incubated with 5 mg/ml of Streptavidin-Alexa Flour 488 (Molecular Probes) for 20 min on ice. The cells were washed twice with Tris-buffered saline and fixed with neutral buffer containing 4% formaldehyde (Nacalai Tesque, Kyoto, Japan) and analyzed by flow cytometry on a FACSCalibur (BD Bioscience) using CELLQuest TM software. Luciferase Assays The plasmids used for transfection were purified using an EndoFree Plasmid Maxi Kit (QIA-GEN). HEK293 cells were plated (5ϫ10 4 cells/well) in 48-well plates on the day prior to transfection. Transfection was performed using Lipofectamine 2000 (invitrogen) according to the manufacturer's recommendations in 48-well plates with 150 ng of plasmid DNA mixture per well. Each DNA mixture consisted of 55 ng of a reporter plasmid mixture and 100 ng of an expression plasmid for Toll-like receptor 2 (TLR2) and Dectin-1. The reporter plasmid mixture consisted of 10 volumes of the pELAM NF-kB-firefly luciferase plasmid and 1 volume of pRL-TK plasmid (Promega). The pELAM luciferase vector was a gift from Dr. Golenbock (University of Massachusetts, Amherst). The transfection mixture was added drop-wise to the cells and incubated for 24 h in DMEM/HAM containing 10% FBS. At 24 h after transfection, the cells were stimulated with Zymosan for 6 h. They were then washed with PBS and lysed by Passive Lysis Buffer (Promega). Luciferase activity was measured using the Dual-Luciferase Reporter Assay System (Promega). The luciferase assay reagents were added to 20 ml of the lysate with an injector, and the results were immediately read with a Microplate Luminometer (EG&G Berthold). Luciferase activity was expressed as the ratio of the ELAM luciferase (firefly) activity to the RL-TK (renilla) activity. The data are representative of at least three different experiments and are presented below as meansϮstandard deviations for duplicate samples.
RESULTS

N-Linked
Glycosylation Site of Dectin-1 Murine Dectin-1 contains two potential N-linked glycosylation consensus sequences in the CRD (Figs. 1A, B) . Human Dectin-1 possesses one in the Stalk region (Figs. 1A, B) . We first examined the effect of PNGase F treatment on the electrophoretic mobility of FLAG-tagged Dectin-1 expressed in HEK 293 cell to elucidate whether the glycosylation sites are actually glycosylated in the cell. The electrophoretic mobility of human Dectin-1A (lanes 1, 2) changed slightly, and that of mouse Dectin-1B (lanes 3, 4), greatly on treatment with PNGase F (Fig. 1C) . On the other hand, the mobility of human Dectin-1B (lanes 5, 6) didn't change (Fig. 1C) . This result suggests that the putative N-linked glycosylation sites on mDectin-1 and hDectin-1 are actually glycosylated and hDectin-1B undergoes no glycosylation.
Cell Surface Expression and Binding to b b-Glucan of Dectin-1 Wild Type Since N-linked glycosylation sometimes modulates the expression and function of cell surface receptors, we first checked the expression on the cell surface and binding to b-glucan of mouse and human Dectin-1 isoforms. Using HEK293 cells, we produced four transfectants of FLAG-tagged wild-type Dectin-1 (mDectin-1A, mDectin-1B, hDectin-1A, and hDectin-1B). Then, we checked their cell surface expression using anti-FLAG antibody and also their ability to bind purified b-glucan, SPG, using biotin-conjugated SPG (SPG-biotin). SPG is a fungal b-glucan purified from Schizophyllum commune that has a 1,6-b-monoglucosyl branch every three 1,3-b-glucosyl residues on the main chain.
22) It is used clinically in Japan to treat cancer of the uterine cervix to enhance the direct antitumor effect of radiation. 25, 26) As a result, both mDectin-1A and B, and hDectin-1A were well expressed on the cell surface and these transfectants were associated with large amounts of SPG (Fig. 2) . But for hDectin-1B, which undergoes no glycosylation, the cell surface expression and binding to b-glucan were reduced compared to levels for the other three glycosylated isoforms (Fig. 2) . These results suggest that N-linked glycosylation on Dectin-1 affects its cell surface expression and ability to bind b-glucan.
Production of Dectin-1 Glycosylation Mutants To investigate the importance of glycosylation on Dectin-1 in detail, we generated mutants deleted of or supplemented with the glycosylation motif. We prepared several mutants of hDectin-1A and mDectin-1B which had mutations introduced into each consensus glycosylation motif (Asn-XSer/Thr) to disrupt their glycosylation (Fig. 3) . In these mutants, the asparagine residue of each motif was replaced with alanine. We also prepared glycosylation addition mutants of hDectin-1B. In these mutants, one or two glycosylation motifs were introduced at the position corresponding to the site of glycosylation on mDectin-1B (Fig. 3) . All the mutants were generated by PCR-mediated mutagenesis using Dectin-1 cDNAs inserted in the p3XFLAG CMV-14 vector. HEK293 cells were transiently transfected with the FLAGtagged mutants, and lysate of 1ϫ10 5 cells of each transfectant was used for SDS-PAGE and Western blotting. Changes in the electrophoretic mobility owing to the deletion or addition of the oligosaccharides were observed (Fig. 3) . The deletion mutants of hDectin-1A (hA-N91A: lane 3) and mDectin-1B (mB-S142A,S190A: lane 10) had the same mass as the respective deglycosylated protein in Fig. 1C . In some mutants, for example lanes 1, 3, 7, and 8, we observed no glycosylated or degraded proteins besides the expected proteins of higher molecular mass. Moreover, the bands of the mutants with mutations introduced at the 188-190th amino acids of hDectin-1B (lanes 5, 6) were weak and bands the same size as wild-type hDectin-1B were also observed. Moreover, no band corresponding to the double glycosylated protein (Asn 140 and Asn
188
) was observed (lane 6). These results indicate that the 188th amino acid of hDectin-1B is not easily glycosylated or else the protein glycosylated at Asn 188 may be degraded. Dectin-1 belongs to the C-type lectin-like NK receptor family, along with CD69, Ly-49, and NKG2. The ultrastructure of this family has been well characterized 27) and six well conserved cysteine (Cys) residues in the CRD are known to play an important role in the formation of the ultrastructure of the CRD. 27) In addition, we previously reported that Cys 232 of mDectin-1A, which corresponds to Cys 187 in mDectin-1B and is one of the six cysteine residues in the CRD, is essential for cell surface expression of the molecule. 15) Since Asn 188 in mutant hDectin-1B is just adjacent to one of the six cysteine residues, Cys 187 , bulky oligosaccharides introduced in Asn 188 might interfere with the folding of the protein and cause degradation. These low expression levels of the Asn 188 mutants of hDectin-1B may affect the subsequent results. The other glycosylation sites (Asn 91 in hDectin-1A, Asp 140 in mDectin-1B, or Asn 138 in hDectin-1B) are not seem to directly influence the conformation when we compare these isoforms with the ultrastructures of other C-type lectin-like NK receptor family molecules.
The Cell Surface Expression and Ligand-Binding Ability of Dectin-1 Glycosylation Mutants Since the levels of expression on the cell surface and binding to b-glucan of hDectin-1B were lower than those of the other three glycosylated isoforms, we investigated the expression and binding of glycosylation deletion mutants of mDectin-1B (mB-S142A, mB-S190A, mB-S142A,S190A) and hDectin-1A (hA-N91A). The molecular expression on the cell surface and total amount of binding were decreased by deleting each or both of the motifs in mDectin-1B (Fig. 4) . Likewise, deleting the motif in hDectin-1A reduced the cell surface expression and binding to b-glucan (Fig. 5) . These results suggest that the glycosylation on Dectin-1 isoforms affects their expression on the cell surface and ability to bind b-glucan.
Then, we next examined the effect of adding glycosylation motifs to hDectin-1B, which originally had none. The levels of cell surface expression and b-glucan-binding of these ad- dition mutants (hB-P140N, hB-S188N, hB-P140N, S188N) were higher than those of the wild type (Fig. 6) . These results further suggest that the molecular glycosylation on Dectin-1 is essential for its cell surface expression and binding to bglucan. Unexpectedly, the mean values for hB-S188N and hB-P140N, S188N seemed to be low compared with those for hB-P140N. These results might correlate with the expression levels in the whole cells in Fig. 3 .
Effect of Dectin-1 Glycosylation on NF-k kB Activation in Collaboration with TLR2
The results so far suggest that the N-linked glycosylation on Dectin-1 modulates its cell surface expression and binding to b-glucan. We next examined if the glycosylation affects the anti-fungal activities mediated by Dectin-1. In innate immunity, it is suggested that several receptors interact with each other and cumulate the effects for anti-microbial responses. 13) Likewise, murine Dectin-1 is known to cooperate with TLR2 in the recognition of the yeast cell wall preparation Zymosan, and enhances the activation of NF-kB via TLR2. 8) The activation of NF-kB is important for the production of inflammatory cytokines such as TNF-a. 28, 29) We therefore examined whether the glycosy- Mouse and human Dectin-1 cDNA inserted into a FLAG-tagged expression vector was introduced into HEK293 cells using FuGENE6 transfection reagent. Transfectants were incubated with biotinylated anti-FLAG antibody or biotinylated SPG. The amounts of anti-FLAG antibody or SPG-biotin bound to the cells were determined by staining with Streptavidin-Alexa Flour 488 conjugate and using fluorescence-activated cell sorting (FACS). Shaded histograms represent Dectin-1 transfectants. Open histograms represent control cells.
Fig. 3. Glycosylation Mutants of Human and Mouse Dectin-1
Dectin-1 glycosylation mutants were constructed by PCR-mediated mutagenesis. Asn or Ser residues at putative N-linked glycosylation sites (Asn-X-Ser/Thr) were replaced with Ala to generate the deletion mutants. Human Dectin-1B glycosylation addition mutants were made by introducing a series of glycosylation amino acids, Asn-XSer. FLAG-tagged expression vectors containing Dectin-1 glycosylation mutants were introduced into HEK293 cells. Cells were lysed in SDS sample buffer containing 15% 2-mercaptoethanol and 1ϫ10 5 cells of the lysate were subjected to SDS-PAGE and Western-blotting using anti-FLAG antibody to check the changes in molecular mass caused by adding or deleting the oligosaccharides.
Fig. 4. Effect of Glycosylation on Mouse Dectin-1B's Expression and Ability to Bind a b-glucan, SPG
The cDNAs of mouse Dectin-1B and its glycosylation deletion mutants in FLAGtagged vectors were introduced into HEK293 cells using FuGENE6 transfection reagent. Transfectants were incubated with biotinylated anti-FLAG antibody or biotinylated SPG. The amounts of anti-FLAG antibody or SPG-biotin bound to the cells were determined by staining with Streptavidin-Alexa Flour 488 conjugate and using FACS. The data were analyzed with CELLQuest and expressed as the geometric mean. The data are the average of the means of two independent experiments, and the error bars indicate the standard error of the mean. lation on Dectin-1 affects .the collaborative activation of NFkB. HEK293 cells were transiently transfected with expression vectors containing wild-type or mutant Dectin-1 isoforms and TLR2 by lipofection. After stimulation with the appropriate amount of Zymosan, the activation of NF-kB was evaluated using a reporter gene assay. The activation via TLR2 was enhanced by the coexpression of wild-type mDectin-1B (mB-WT) and was significantly decreased by deleting each or both of the sites of glycosylation (Fig. 7) . Likewise, the enhancement by hDectin-1A was slightly decreased by deleting its site of glycosylation at Asp 91 (Fig.  8A) . Meanwhile, glycosylation at the 140th and/or 188th amino acid of hDectin-1B (hB-P140N, hB-S180N, and hB-P140NS180N) promoted the activation of NF-kB (Fig. 8B) . These results suggest that the N-linked glycosylation on Dectin-1 also influences the enhancing effect on the activation of NF-kB, which seems to be important for anti-fungal activity mediated by a combination of Dectin-1 and TLR2.
Thus we demonstrated that N-linked glycosylation on Dectin-1 regulates the cell surface expression and affects not The cDNAs of human Dectin-1A and its glycosylation deletion mutant in FLAGtagged vectors were introduced into HEK293 cells using FuGENE6 Transfection Reagent. Transfectants were incubated with biotinylated anti-FLAG antibody or biotinylated SPG. The amounts of anti-FLAG antibody or SPG-biotin bound to the cells were determined by staining with Streptavidin-Alexa Flour 488 conjugate and using FACS. The data were analyzed with CELLQuest and expressed as the geometric mean. The data are the average of the means of two independent experiments, and the error bars indicate the standard error of the mean. The cDNAs of human Dectin-1B and its glycosylation addition mutants in FLAGtagged vectors were introduced into HEK293 cells using FuGENE6 transfection reagent. Transfectants were incubated with biotinylated anti-FLAG antibody or biotinylated SPG. The amounts of anti-FLAG antibody or SPG-biotin bound to the cells were determined by staining with Streptavidin-Alexa Flour 488 conjugate and using FACS. The data were analyzed with CELLQuest and expressed as the geometric fluorescence mean. The data are the average of the means of two independent experiments, and the error bars indicate the standard error of the mean. After further incubation for 6 h, cells were lysed in passive lysis buffer. The activation of NF-kB was monitored by measuring relative luciferase activity using a dual luciferase reporter gene assay system. Relative luciferase activity was obtained by dividing Firefly luciferase units by Renilla luciferase units. Fig. 8 . Glycosylation of Dectin-1 Affects Activation of NF-kB via TLR2/hDectin-1 in Response to Zymosan HEK293 cells were transiently transfected with 150 ng of plasmid mixture using Lipofectamine 2000 transfection reagent. Each plasmid mixture contained 55 ng of reporter plasmid and 100 ng of mTLR2 and/or Dectin-1 (Dec-1) expression plasmid. The reporter plasmid mixture consisted of 10 volumes of the pELAM NF-kB fireflyluciferase plasmid and 1 volume of pRL-TK plasmid as an internal control for transfection efficiency. Transfected cells were incubated in DMEM/HAM medium containing 10% fetal bovine serum. At 24 h after transfection, cells were stimulated with Zymosan, a yeast cell wall preparation containing b-1,3-glucan. After further incubation for 6 h, cells were lysed in passive lysis buffer. The activation of NF-kB was monitored by measuring relative luciferase activity using a dual luciferase reporter gene assay system. Relative luciferase activity was obtained by dividing Firefly luciferase units by Renilla luciferase units.
only the binding of b-glucan on the cell surface but also the enhancement of the activation of NF-kB via TLR2 which is one of the anti-fungal activities mediated by Dectin-1.
DISCUSSION
It has been reported that Dectin-1 is involved in the recognition of fungal b-glucan and mediates the production of proinflammatory cytokines and reactive oxygen species. 9, 10) Therefore, Dectin-1 is thought to be essential for the innate immune response to fungal infection. Several of the motifs in Dectin-1 involved in these functions are becoming clear. Brown GD and others have reported that an ITAM-like motif in the cytoplasmic tail is involved in the production of cytokines and internalization of Zymosan. 8, 10) We recently reported that the amino acid sequence Trp-Ile-His (WIH) in the CRD is essential for the recognition of b-glucan. 15) Two isoforms of human Dectin-1 (hDectin-1A and hDectin-1B) also have these motifs and are involved in the recognition of fungal b-glucan. 16) Since each of these isoforms is structurally similar to the corresponding mouse isoforms and all four have the motifs required for responding to b-glucan, they seem to be functionally equivalent as a b-glucan receptor. However, one major difference among the mouse and human isoforms is the position and number of N-linked glycosylation sites. N-Linked glycosylation is widely found in cell surface receptors. The importance of N-linked glycosylation has been widely reported and oligosaccharides can be crucial for stabilizing glycoproteins, molecular folding, and intracellular trafficking. 18, 30) They sometimes modulate the cell surface expression and functions of a molecule. 18, 30) However, the importance of N-linked glycosylation on Dectin-1 was not clear.
We showed that hDectin-1B, which undergoes no glycosylation, showed reduced cell surface expression and binding to b-glucan compared with the other three glycosylated isoforms (Fig. 2) , and both the expression and binding were improved by the addition of N-linked glycosylation motifs (Fig.  6 ). On the other hand, mutations in the glycosylation motifs in the other glycosylated isoforms resulted in a decrease in the expression and ligand-binding (Figs. 4, 5) . These results suggest that N-linked glycosylation on Dectin-1 affects its cell surface expression and ability to bind ligands.
The whole cell expression of hDectin-1B in Fig. 3 was enough observed suggesting that the protein synthesis would be almost the same level as that of hDectin-1A, but hDectin-1B is not enough transported to the cell surface and remains inside of the cell. Recently, diverse effects of N-linked glycosylation have been reported, for example, an increase in the hydrophilicity of the protein which keeps it in solution during the folding process, stabilization of the protein structure, and protection against proteolysis.
18) N-Linked glycosylation is also important for the quality control of proteins in the endoplasmic reticulum (ER). In the ER, the glucose moiety of the N-linked oligosaccharide intermediate is recognized by lectin-like chaperon molecules, calnexin, and calreticulin. 31, 32) The proper folding of a protein is supported by these chaperon molecules, and the N-linked glycoproteins become easier to express on the cell surface. Since hDectin-1B can't gain these benefits particular to N-linked glycoproteins, the cell surface expression may be reduced compared with that of the other glycosylated isoforms, reducing its ligand-binding activity. These results indicate that in terms of the level of expression on the cell surface in humans, hDectin-1A is superior to hDectin-1B. But recently, Willment JA and his colleagues revealed that the expression of the human isoforms in vivo is cell specific. 33) There may be some other factor regulating the expression besides glycosylation, such as the regulation of mRNA splicing.
Among glycoproteins, oligosaccharides sometimes directly modulate ligand-binding activities. For instance, among the C-type lectin family, Lox-1 requires N-linked oligosaccharides for its cell surface expression and full ligand-binding activity. 20) In contrast, one of the oligosaccharides on Ly-49 interferes with the binding of receptors to its MHC class I ligand H-2D d . 21) On the other hand, the oligosaccharides on E-selectin are important for its cell surface expression but not for its binding to ligands. 19) In our results, the fluctuation in the level of binding to b-glucan on the deletion or addition of oligosaccharides paralleled that in the level of cell surface expression. Additionally, hDectin-1B and other none glycosylated mutants (hA-N91A and mB-N142A, N180A) did not fully lose their glucan-binding ability. These results indicate that N-linked glycosylation does not directly affect the binding of b-glucan. It seems that Nlinked glycosylation is important for the cell surface expression of the C-type lectin family but its role in ligand-binding may differ among molecules.
We additionally demonstrated that the glycosylation on Dectin-1 also affects the enhancement of the activation of NF-kB via TLR2 by zymosan. The activation of NF-kB is essential for the production of proinflammatory cytokines in response to fungal infections, and thus the collaboration of Dectin-1 and TLR2 is very important for the anti-fungal immune responses. Whole cell expression of mDectin-1 glycosylation deletion mutants in Fig. 3 was observed, but the enhancement of the activation of NF-kB by these mutants was decreased compared with that for the wild type suggesting that intracellular Dectin-1 does not participate in the activation with TLR2. These results are consistent with the previous report that inhibition of the internalization of zymosan particles mediated by Dectin-1 enhanced the production of cytokines. 10) These results indicate that the collaborative activation of NF-kB is mediated by cell surface Dectin-1 and TLR2. As we revealed that the cell surface expression of Dectin-1 is regulated by glycosylation, the activation is indirectly affected by glycosylation. Interestingly, the effect of glycosylation on the activation of NF-kB was smaller with hDectin-1 than mDectin-1. This difference may due to the difference in the original enhancer activity of human and mouse Dectin-1. The enhancer activity of wild type hDectin-1 on the activation of NF-kB may be originally less than that of mDectin-1. Therefore, the effect of glycosylation on this function through hDectin-1 seemed to be small. It may be that human anti-fungal responses require pathways other than TLR2/Dectin-1 NF-kB activation.
In this paper, we have shown that N-linked glycosylation on murine and human Dectin-1 modulates the cell surface expression, and even affects the binding of ligands and collaborative anti-fungal effects with TLR2. Our results indicate that the difference in N-linked glycosylation between the human and mouse isoforms causes the species-specific dif-ference in the response to b-glucan in vivo. However, further study is needed of the species-specific difference in the responses to b-glucan and the role of alternatively spliced isoforms.
